CN101260152A - 负调节Osteoprotegerin配体活性的方法 - Google Patents

负调节Osteoprotegerin配体活性的方法 Download PDF

Info

Publication number
CN101260152A
CN101260152A CNA2007101927772A CN200710192777A CN101260152A CN 101260152 A CN101260152 A CN 101260152A CN A2007101927772 A CNA2007101927772 A CN A2007101927772A CN 200710192777 A CN200710192777 A CN 200710192777A CN 101260152 A CN101260152 A CN 101260152A
Authority
CN
China
Prior art keywords
opgl
ser
leu
gly
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101927772A
Other languages
English (en)
Chinese (zh)
Inventor
托本·哈尔基尔
杰斯珀·哈宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHAMACSA AS
Affitech AS
Original Assignee
PHAMACSA AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHAMACSA AS filed Critical PHAMACSA AS
Publication of CN101260152A publication Critical patent/CN101260152A/zh
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA2007101927772A 1998-09-15 1999-09-13 负调节Osteoprotegerin配体活性的方法 Pending CN101260152A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199801164 1998-09-15
DKPA199801164 1998-09-15
US60/102,896 1998-10-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN99810872A Division CN1318105A (zh) 1998-09-15 1999-09-13 负调节Osteoprotegerin配体活性的方法

Publications (1)

Publication Number Publication Date
CN101260152A true CN101260152A (zh) 2008-09-10

Family

ID=27675500

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101927772A Pending CN101260152A (zh) 1998-09-15 1999-09-13 负调节Osteoprotegerin配体活性的方法

Country Status (4)

Country Link
CN (1) CN101260152A (sh)
EA (1) EA006940B1 (sh)
RS (1) RS49960B (sh)
ZA (1) ZA200102131B (sh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019061297A1 (zh) * 2017-09-29 2019-04-04 苏州工业园区唯可达生物科技有限公司 一种cd4辅助性t细胞表位融合肽及其疫苗
CN110923266A (zh) * 2019-11-07 2020-03-27 苏州工业园区唯可达生物科技有限公司 一种重组病毒载体、包含其的免疫组合物以及用途

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019061297A1 (zh) * 2017-09-29 2019-04-04 苏州工业园区唯可达生物科技有限公司 一种cd4辅助性t细胞表位融合肽及其疫苗
CN109575142A (zh) * 2017-09-29 2019-04-05 苏州工业园区唯可达生物科技有限公司 一种cd4辅助性t细胞表位融合肽及其疫苗
CN109575142B (zh) * 2017-09-29 2022-07-12 苏州工业园区唯可达生物科技有限公司 一种cd4辅助性t细胞表位融合肽及其疫苗
CN110923266A (zh) * 2019-11-07 2020-03-27 苏州工业园区唯可达生物科技有限公司 一种重组病毒载体、包含其的免疫组合物以及用途

Also Published As

Publication number Publication date
RS49960B (sr) 2008-09-29
YU19701A (sh) 2005-06-10
ZA200102131B (en) 2002-06-14
EA006940B1 (ru) 2006-06-30
EA200100356A1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
US6645500B1 (en) Method for down-regulating osteoprotegerin ligand activity
US7070784B1 (en) Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues
CA2687533C (en) Immunological methods to modulate myostatin in vertebrate subjects
JP4446601B2 (ja) B群連鎖球菌の糖質を免疫学的に模倣する抗イディオタイプ抗体を含むワクチン処方物
TW510921B (en) Modified TNFα molecules, DNA encoding such modified TNFα molecules and vaccines comprising such modified TNFα molecules and DNA
CZ168296A3 (en) Spermatic antigen corresponding to auto-antigenic epitope of spermatic bond protein
US5098998A (en) Cholera vaccines and peptides
US20080253993A1 (en) Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope
CA2467052A1 (en) Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
CN1639569B (zh) 诱导免疫应答的方法和组合物
US5330753A (en) Cholera vaccines
CN101260152A (zh) 负调节Osteoprotegerin配体活性的方法
MXPA02006313A (es) Vacunacion de acido nucleico.
US20060222624A1 (en) Detoxified TNF and method of preparing
US20060013822A1 (en) Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines
HALKIER et al. Sommaire du brevet 2343654
HALKIER et al. Patent 2343654 Summary
EP1541587A2 (en) Method for down-regulating osteoprotegerin ligand activity
MXPA00008032A (en) Immunological methods to modulate myostatin in vertebrate subjects

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080910